Lipids: Eprotirome shows promise as a novel way to target dyslipidemia
- PMID: 20583340
- DOI: 10.1038/nrendo.2010.74
Lipids: Eprotirome shows promise as a novel way to target dyslipidemia
Comment on
-
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.N Engl J Med. 2010 Mar 11;362(10):906-16. doi: 10.1056/NEJMoa0905633. N Engl J Med. 2010. PMID: 20220185 Clinical Trial.
References
-
- N Engl J Med. 2010 Mar 11;362(10):906-16 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
